112 related articles for article (PubMed ID: 16460841)
1. Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Abeta.
Head E; Barrett EG; Murphy MP; Das P; Nistor M; Sarsoza F; Glabe CC; Kayed R; Milton S; Vasilevko V; Milgram NW; Agadjanyan MG; Cribbs DH; Cotman CW
Vaccine; 2006 Apr; 24(15):2824-34. PubMed ID: 16460841
[TBL] [Abstract][Full Text] [Related]
2. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
[TBL] [Abstract][Full Text] [Related]
3. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
4. Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.
Vasilevko V; Pop V; Kim HJ; Saing T; Glabe CC; Milton S; Barrett EG; Cotman CW; Cribbs DH; Head E
Neurobiol Dis; 2010 Sep; 39(3):301-10. PubMed ID: 20451612
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
[TBL] [Abstract][Full Text] [Related]
6. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
[TBL] [Abstract][Full Text] [Related]
7. Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives.
Trouche SG; Asuni A; Rouland S; Wisniewski T; Frangione B; Verdier JM; Sigurdsson EM; Mestre-Francés N
Vaccine; 2009 Feb; 27(7):957-64. PubMed ID: 19114076
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes.
Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL
Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509
[TBL] [Abstract][Full Text] [Related]
9. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.
Lemere CA; Beierschmitt A; Iglesias M; Spooner ET; Bloom JK; Leverone JF; Zheng JB; Seabrook TJ; Louard D; Li D; Selkoe DJ; Palmour RM; Ervin FR
Am J Pathol; 2004 Jul; 165(1):283-97. PubMed ID: 15215183
[TBL] [Abstract][Full Text] [Related]
11. Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology.
Movsesyan N; Davtyan H; Mkrtichyan M; Petrushina I; Tiraturyan T; Ross T; Agadjanyan MG; Ghochikyan A; Cribbs DH
Hum Gene Ther; 2010 Nov; 21(11):1569-76. PubMed ID: 20528468
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
13. Preventive immunization of aged and juvenile non-human primates to β-amyloid.
Kofler J; Lopresti B; Janssen C; Trichel AM; Masliah E; Finn OJ; Salter RD; Murdoch GH; Mathis CA; Wiley CA
J Neuroinflammation; 2012 May; 9():84. PubMed ID: 22554253
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.
Cribbs DH; Ghochikyan A; Vasilevko V; Tran M; Petrushina I; Sadzikava N; Babikyan D; Kesslak P; Kieber-Emmons T; Cotman CW; Agadjanyan MG
Int Immunol; 2003 Apr; 15(4):505-14. PubMed ID: 12663680
[TBL] [Abstract][Full Text] [Related]
15. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42.
Axelsen TV; Holm A; Christiansen G; Birkelund S
Vaccine; 2011 Apr; 29(17):3260-9. PubMed ID: 21371581
[TBL] [Abstract][Full Text] [Related]
16. Active immunization of mice with an Abeta-Hsp70 vaccine.
Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
[TBL] [Abstract][Full Text] [Related]
17. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice.
Li Y; Ma Y; Zong LX; Xing XN; Guo R; Jiang TZ; Sha S; Liu L; Cao YP
J Neuroimmunol; 2012 Aug; 249(1-2):16-26. PubMed ID: 22626444
[TBL] [Abstract][Full Text] [Related]
18. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
Matsuda J; Kaminaka K; Nozaki C
Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
[TBL] [Abstract][Full Text] [Related]
20. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system.
Vollmar P; Kullmann JS; Thilo B; Claussen MC; Rothhammer V; Jacobi H; Sellner J; Nessler S; Korn T; Hemmer B
J Immunol; 2010 Nov; 185(10):6338-47. PubMed ID: 20943998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
